Bray Patrick-Lake serves as President and CEO of the PFO Research Foundation. Ms. Patrick-Lake founded the organization in response to the lack of definitive scientific information regarding the condition of PFO, which she was diagnosed with after suffering hemiplegic migraine. In 2008, she underwent PFO closure through a clinical trial investigating the relationship between PFO and migraine.
Professionally, Ms. Patrick-Lake serves as the Director of Stakeholder Engagement for the Clinical Trials Transformation Initiative (CTTI), which is an FDA public-private partnership with Duke University that engages patients, academia, industry, government, CROs and IRBs in improving the quality and efficiency of clinical trials. Ms. Patrick-Lake supports efforts to actively engage patient advocacy organizations and other stakeholders in CTTI efforts to improve clinical trials. She also implements strategies to enhance awareness of CTTI’s work, particularly with patient advocates, and to extend the impact of CTTI results and recommendations. During the past 15 years, Ms. Patrick-Lake has founded and led several non-profit organizations. Ms. Patrick-Lake has served as a patient representative at the FDA on a variety of advisory committees and panels, in workgroups for EMA and NIH/NINDS, as a guest lecturer and an external reviewer for IOM, and as a key stakeholder for AHRQ and PCORI grants. She is a member of the ACC Foundation Patient-centered Care (PC3) Shared Decision Making Workgroup, the DIA Patient Fellowship Selection Committee, the TVT Registry Stakeholder Advisory Committee, and is a board member for the Alliance for Headache Disorders Advocacy. She is a frequent guest lecturer on patient issues and clinical trials, both nationally and internationally, and is an avid rock climber. She holds a BS (zoology) from University of Georgia and a master of forensic sciences degree from National University in La Jolla, CA.